en · de · es · fr · pt
cardarine-notes.peptides3081.com › Wiki › Background And Regulatory Status — Research Overview

Background And Regulatory Status — Research Overview

By Editorial Desk · published 2025-07-23 · last reviewed 2025-08-10 · Wiki

If you have been reading about unapproved substance and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-08-10. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Regulatory Status

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Cardarine Identity and Mechanism

At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.

Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.

Cardarine at a glance

PropertyValueNotes
IUPAC name{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acidSystematic name for GW501516
CAS Registry Number317318-70-0Unique identifier for the parent compound
Molecular formulaC21H18F3NO3S2Includes carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur
Molecular weight453.5 g/molApproximate value for the neutral form
AppearanceWhite to off-white powderTypical description for purified laboratory material

Cardarine as Investigational PPARδ Agonist

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Related pages on this site

Detection, Stability, and Quality

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Further detail

== AFL career == Lovett-Murray was initially rookie listed by Collingwood, playing for the Williamstown Seagulls in the Victorian Football League. After switching to the Bendigo Bombers, he was rookie listed by Essendon in the 2003 Rookie Draft. Lovett-Murray was promoted to the senior list early in the 2004 season and played 20 games. He spent the 2005 season on the rookie list again, he was promoted again that season and stayed on the senior list since then. In 2006, Lovett-Murray copped a three-game suspension from the AFL Tribunal for intentionally striking Fremantle midfielder Matthew Carr in the Bombers' round fourteen loss to the Dockers at Subiaco Oval. This was one of many lowlights for the club, which finished 15th at the end of the season with just three wins and one draw from 22 matches played. Lovett-Murray, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his team-mates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, but a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency. He was suspended for two years which, with backdating, ended in December 2016; as a result, he served approximately fifteen months of his suspension and missed the entire 2016 season, when he had intended to play and coach for Rumbalara Football Club.

While there are many rehabilitation centres for wealthy people struggling with addiction in South Africa there are very few facilities for the poor. Some have argued that people struggling with heroin addiction are treated as the 'undeserving poor' and subject to policing rather than medical interventions. In the populous province of KwaZulu-Natal there are only two government rehab centres accessible by poor people.

=== Acid dissolution === Acids can be used to learn more about fossil eggs. Diluted acetic acid or EDTA can be used to expose the microstructure of shell that has been damaged by weathering. Acids are also used to extract embryo skeletons from the egg encasing them. Even fossilized soft tissue like muscle and cartilage as well as fat globules from the original egg yolk can be uncovered using this method. Amateur paleontologist Terry Manning has been credited with groundbreaking work developing this technique. First, the paleontologist must submerge the egg in a very dilute phosphoric acid bath. Since the acid solution can penetrate the egg, every few days the specimen must be soaked in distilled water to prevent the acid from damaging the embryo before it is even exposed. If embryonic fossil bone is revealed after drying from the water bath, the exposed fossils must be delicately cleaned with fine instruments like needles and paint brushes. The exposed bone is then coated with plastic preservatives like Acryloid B67, Paraloid B72, or Vinac B15 to protect it from the acid when submerged for another round. The complete process can take months before the whole embryo is revealed. Even then only about 20% of the eggs subjected to the process reveal any embryo fossils at all.

== History == EcPLA was first described in the scientific literature by a team that included Adam Halberstadt, Alexander Stratford, Jason Wallach, and David E. Nichols in 2019. It was developed by Lizard Labs. The drug was encountered online as a novel designer drug in around 2020 and became more widely available in early 2022.

Sources: en.wikipedia.org

Supporting material

Besides platformer gameplay, one of the game's most distinctive gameplay features is allowing to switch the player character's form to suit one's needs. The player begins the game as Maui, whose only means of self-defence is an insect-launching pistol that can launch several forms of bugs, some of them combined for greater effect. However, once the player reaches the second level, Maui transforms into Cold Shadow, his ninja alter ego, who defends himself with short-range attacks using a bo staff. Cold Shadow's staff is also primarily used to explore the level further, such as climbing a narrow tunnel. After the second level, the player can switch back and forth between Maui and Cold Shadow at will, provided he has enough ninja tokens for the transformation. The amount of ninja tokens Maui or Cold Shadow holds determines Cold Shadow's strength – who can then chain more and more attacks as his skill improves – when played as him in the SNES version. On Mega Drive, however, Maui needs to collect red ninja tokens instead, the amount of white tokens being useful for metamorphosis alone. Some levels of the game, however, prevent Maui from transforming at all, as Cold Shadow cannot bungee jump on vines, for example, which forces the player to use Maui throughout the level.

== External links == "Rusfertide ( Code - C162883 )". EVS Explore. "Rusfertide Acetate ( Code - C180660 )". EVS Explore. Clinical trial number NCT05210790 for "A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera (VERIFY)" at ClinicalTrials.gov

Rutherford deduced the existence of the atomic nucleus through his experiments but he had nothing to say about how the electrons were arranged around it. In 1912, Niels Bohr joined Rutherford's lab and began his work on a quantum model of the atom. Max Planck in 1900 and Albert Einstein in 1905 had postulated that light energy is emitted or absorbed in discrete amounts known as quanta (singular, quantum). This led to a series of atomic models with some quantum aspects, such as that of Arthur Erich Haas in 1910 and the 1912 John William Nicholson atomic model with quantized angular momentum as h/2π. Critically, Nicholson successfully reproduces atomic spectral lines, a challenge that Bohr's model would also need to overcome. When Bohr learned from a friend about Balmer's compact formula for the spectral line data, Bohr quickly realized his model would match it in detail. In 1913, Bohr published a trilogy of papers developing his model of the atom based on two hypothesis: 1) an electron could change states only by "quantum leaps" and 2) the jump corresponds to a emission of light according to Planck relation. With these assumptions, the instability of the older models becomes irrelevant and the classical electrodynamics of Maxwell is considered invalid. Using circular orbits for simplicity, Bohr could then derived Balmer's spectral formula. Balmer's formula contained a constant now known as the Rydberg constant with a value known only by matching experimental results.

==== Regulations ==== Hitchens was known for his dislike of Nanny state policies put in place by New York city mayor Michael Bloomberg. On 9 July 2009, Hitchens wrote an article criticizing and mocking New York city regulations including smoking laws, bicycle laws, milk crate laws and other regulations. In the same article Hitchens claimed he had broken the laws he had criticized in the article.

=== Megaloblastic anemia === Neutrophil hypersegmentation is one of the earliest, most sensitive and specific signs of megaloblastic anemia (mainly caused by hypovitaminosis of vitamin B12 & folic acid). Nuclear hypersegmentation of DNA in neutrophils strongly suggests megaloblastosis when associated with macro-ovalocytosis. If megaloblastosis is suspected, a formal lobe count/neutrophil (i.e. lobe index) above 3.5% can be obtained. Hypersegmentation persists for an average of 14 days after institution of specific therapy.

Sources: en.wikipedia.org

Supporting material

== Upcoming Peptide Facility == Neuland Laboratories is set to commission a new commercial peptide manufacturing facility at its 17- acre Bonthapally manufacturing campus in the summer of 2026. The project is part of a phased expansion, with additional capacity planned in line with growing client demand. The first of four modules is expected to be operational by mid-2026, adding commercial scale capabilities to its existing peptide manufacturing infrastructure. The new peptide manufacturing facility will feature digitalized operations supported by distributed control system (DCS) automation and electronic batch‑record platforms. It is also designed with expanded purification and drying infrastructure, including multi‑column preparative HPLC systems, large‑scale lyophilizers, enhanced solvent‑handling capabilities, and upgraded waste‑management processes. These features are intended to support consistent batch quality and more efficient production cycles.

Opium production has led to rising tensions in Afghan villages. Though direct conflict has yet to occur, the opinions of the new class of young rich men involved in the opium trade are at odds with those of the traditional village leaders.

Seizures Haemorrhage † Myelosuppression, including: thrombocytopenia, anaemia, neutropenia and lymphopenia, in descending order of frequency. Omacetaxine mepesuccinate can cause fetal harm when administered to a pregnant woman. Women using HHT should avoid becoming pregnant and also avoid nursing while receiving HHT.

===== Role in insecticides ===== Insect 5-HT receptors have similar sequences to the vertebrate versions, but pharmacological differences have been seen. Invertebrate drug response has been far less characterized than mammalian pharmacology and the potential for species selective insecticides has been discussed.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for human use?

No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.

Why is cardarine banned in sport?

It is prohibited by the World Anti-Doping Agency as a hormone and metabolic modulator. Athletes who test positive for GW501516 can face sanctions, including suspensions and loss of results.

What is the difference between cardarine and GW501516?

Cardarine is a common or trade-style name, while GW501516 is the research code for the same chemical entity. Some sources also use Endurobol or GSK-516. The names refer to the same compound, not distinct drugs.

What is cardarine?

Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.

Network